| Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma A Fard-Esfahani, A Emami-Ardekani, B Fallahi, P Fard-Esfahani, D Beiki, ... Nuclear medicine communications 35 (8), 808-817, 2014 | 158 | 2014 |
| Low versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma: a large randomized clinical trial B Fallahi, D Beiki, A Takavar, A Fard-Esfahani, KA Gilani, M Saghari, ... Nuclear medicine communications 33 (3), 275-282, 2012 | 107 | 2012 |
| Incidence of second primary malignancies during a long-term surveillance of patients with differentiated thyroid carcinoma in relation to radioiodine treatment B Fallahi, K Adabi, M Majidi, A Fard-Esfahani, R Heshmat, B Larijani, ... Clinical nuclear medicine 36 (4), 277-282, 2011 | 63 | 2011 |
| Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? B Fallahi, D Beiki, SM Abedi, M Saghari, A Fard-Esfahani, F Akhzari, ... Nuclear medicine communications 34 (8), 777-786, 2013 | 58 | 2013 |
| The effect of high-dose radioiodine treatment on lacrimal gland function in patients with differentiated thyroid carcinoma A Fard-Esfahani, H Mirshekarpour, B Fallahi, M Eftekhari, M Saghari, ... Clinical Nuclear Medicine 32 (9), 696-699, 2007 | 50 | 2007 |
| Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs. AF Esfahani, VR Kakhki, B Fallahi, M Eftekhari, D Beiki, M Saghari, ... Hellenic journal of nuclear medicine 8 (3), 158-161, 2005 | 49 | 2005 |
| Frequency and severity of myocardial perfusion abnormalities using Tc-99m MIBI SPECT in cardiac syndrome X M Saghari, M Assadi, M Eftekhari, M Yaghoubi, A Fard-Esfahani, ... BMC Medical Physics 6 (1), 1, 2006 | 47 | 2006 |
| 99mtc-Ubiquicidin [29–41], a promising radiopharmaceutical to differentiate orthopedic implant infections from sterile inflammation D Beiki, G Yousefi, B Fallahi, MN Tahmasebi, A Gholamrezanezhad, ... Iranian journal of pharmaceutical research: IJPR 12 (2), 347, 2013 | 41 | 2013 |
| Diagnostic efficiency of 68Ga-DOTATATE PET/CT as compared to 99mTc-Octreotide SPECT/CT and conventional morphologic modalities in neuroendocrine tumors B Fallahi, R Manafi-Farid, M Eftekhari, A Fard-Esfahani, ... Asia Oceania Journal of Nuclear Medicine and Biology 7 (2), 129, 2019 | 40 | 2019 |
| Prognostic significance of sentinel lymph node mapping in Merkel cell carcinoma: systematic review and meta-analysis of prognostic studies R Sadeghi, Z Adinehpoor, M Maleki, B Fallahi, L Giovanella, G Treglia BioMed research international 2014, 2014 | 40 | 2014 |
| Radioiodine treatment complications to the mother and child in patients with differentiated thyroid carcinoma A Fard-Esfahani, M Hadifar, B Fallahi, D Beiki, M Eftekhari, M Saghari, ... Hell J Nucl Med 12 (1), 37-40, 2009 | 34 | 2009 |
| Evaluation of 99mTc-TRODAT-1 SPECT in the diagnosis of Parkinson’s disease versus other progressive movement disorders B Fallahi, A Esmaeili, D Beiki, S Oveisgharan, H Noorollahi-Moghaddam, ... Annals of nuclear medicine 30, 153-162, 2016 | 32 | 2016 |
| Predictors of abnormal renal cortical scintigraphy in children with first urinary tract infection: the importance of time factor K Ansari Gilani, J Modaresi Esfeh, A Gholamrezanezhad, A Gholami, ... International urology and nephrology 42, 1041-1047, 2010 | 32 | 2010 |
| 99mTc-PSMA SPECT/CT versus 68Ga-PSMA PET/CT in the evaluation of metastatic prostate cancer B Fallahi, N Khademi, N Karamzade-Ziarati, A Fard-Esfahani, ... Clinical Nuclear Medicine 46 (2), e68-e74, 2021 | 30 | 2021 |
| Nasolacrimal duct obstruction as a complication of iodine-131 therapy in patients with thyroid cancer A Fard-Esfahani, S Farzanefar, B Fallahi, D Beiki, M Saghari, ... Nuclear Medicine Communications 33 (10), 1077-1080, 2012 | 30 | 2012 |
| Assessment of the accuracy of lacrimal scintigraphy based on a prospective analysis of patients' symptomatology A Fard-Esfahani, A Gholamrezanezhad, S Mirpour, AS Tari, M Saghari, ... Orbit 27 (4), 237-241, 2008 | 30 | 2008 |
| The long term effect of levothyroxine on bone mineral density in patients with well differentiated thyroid carcinoma after treatment M Eftekhari, A Asadollahi, D Beiki, S Izadyar, A Gholamrezanezhad, ... Hell J Nucl Med 11 (3), 160-163, 2008 | 29 | 2008 |
| Brain perfusion single photon emission computed tomography findings in patients with posttraumatic anosmia and comparison with radiological imaging M Eftekhari, M Assadi, M Kazemi, M Saghari, A Mojtahedi, ... American journal of rhinology 20 (6), 577-581, 2006 | 27 | 2006 |
| Semi-quantitative assessment of salivary gland function in patients with differentiated thyroid carcinoma after radioiodine-131 treatment. AF Esfahani, B Fallahi, R Olamaie, M Eftekhari, D Beiki, M Saghari Hellenic Journal of Nuclear Medicine 7 (3), 206-209, 2004 | 27 | 2004 |
| Evaluation of radioiodine therapy in differentiated thyroid cancer subjects with elevated serum thyroglobulin and negative whole body scan using 131I with … A Zakani, M Saghari, M Eftekhari, A Fard-Esfahani, B Fallahi, J Esmaili, ... European Review for Medical & Pharmacological Sciences 15 (10), 2011 | 24 | 2011 |
Davood BeikiProfessor of Nuclear Pharmacy, Research Center for Nuclear Medicine, TUMS, Tehran, IranVerified email at sina.tums.ac.ir
